Correlation Between Citigroup and Nykode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Citigroup and Nykode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Nykode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Nykode Therapeutics ASA, you can compare the effects of market volatilities on Citigroup and Nykode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Nykode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Nykode Therapeutics.
Diversification Opportunities for Citigroup and Nykode Therapeutics
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Citigroup and Nykode is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Nykode Therapeutics ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nykode Therapeutics ASA and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Nykode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nykode Therapeutics ASA has no effect on the direction of Citigroup i.e., Citigroup and Nykode Therapeutics go up and down completely randomly.
Pair Corralation between Citigroup and Nykode Therapeutics
Taking into account the 90-day investment horizon Citigroup is expected to generate 0.36 times more return on investment than Nykode Therapeutics. However, Citigroup is 2.82 times less risky than Nykode Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Nykode Therapeutics ASA is currently generating about -0.09 per unit of risk. If you would invest 4,651 in Citigroup on September 1, 2024 and sell it today you would earn a total of 2,436 from holding Citigroup or generate 52.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 99.78% |
| Values | Daily Returns |
Citigroup vs. Nykode Therapeutics ASA
Performance |
| Timeline |
| Citigroup |
| Nykode Therapeutics ASA |
Citigroup and Nykode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citigroup and Nykode Therapeutics
The main advantage of trading using opposite Citigroup and Nykode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Nykode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nykode Therapeutics will offset losses from the drop in Nykode Therapeutics' long position.| Citigroup vs. JPMorgan Chase Co | Citigroup vs. Wells Fargo | Citigroup vs. Toronto Dominion Bank | Citigroup vs. Nu Holdings |
| Nykode Therapeutics vs. Equinor ASA | Nykode Therapeutics vs. DnB ASA | Nykode Therapeutics vs. Aker BP ASA | Nykode Therapeutics vs. Telenor ASA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |